Veefin Solutions Regulatory Approval

SME to Main Board MigrationAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Veefin Solutions SME to Main Board Migration

Veefin Solutions received final listing approval to migrate 2,55,39,417 equity shares from the BSE SME platform to the main boards of BSE and NSE, effective 11 November 2026. This is a migration step with no new capital or monetary amount.

Other Announcement

Veefin Solutions Other Announcement

Veefin Solutions applied to NSE for in-principle listing approval, a voluntary step. No monetary impact or penalty is stated.

SME to Main Board MigrationAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Veefin Solutions SME to Main Board Migration

Veefin Solutions received NSE in-principle approval to migrate its equity shares from the BSE SME platform to the NSE Main Board. Final listing formalities are pending, with trading start to follow.

Insolvency Petition

Veefin Solutions Insolvency Petition

Veefin Solutions disclosed that Epikindifi Software, a disputed step-down subsidiary, filed a Section 9 IBC petition at NCLT Mumbai seeking CIRP against the company over a disputed INR 1.27 Crore claim. The company strongly contests the petition and will defend it.

Value

₹1.27 Cr

Results Update

Veefin Solutions Results Update

Veefin reported H1 FY27 revenue of ₹238.82 Cr (up 116% YoY) and PAT of ₹24.85 Cr. The company highlighted a ₹920 Cr opportunity pipeline in banking technology.

Earnings Call

Veefin Solutions Investor Presentation: Key Takeaways

H1 FY27 group revenue ₹238.82 cr (+116.2% YoY), PAT ₹24.85 cr (+126.6%), EBITDA margin 25.5%. Standalone Q2 PAT flat; ₹920 cr pipeline, 84% outside India.

Regulatory ApprovalSandur Manganese & Iron Ores Ltd SANDUMAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sandur Manganese & Iron Ores Regulatory Approval

Sandur Manganese received environmental clearance to raise iron ore capacity to 9.42 MTPA. No rupee value is disclosed in the filing.

iron ore RoM capacity

9.42 MTPA

Regulatory ApprovalNeogen Chemicals Ltd NEOGENAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Neogen Chemicals Regulatory Approval

Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.

Regulatory ApprovalArihant Capital Markets Ltd ARIHANTCAPAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Arihant Capital Markets Regulatory Approval

Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.

Regulatory ApprovalDr. Reddy's Laboratories Ltd DRREDDYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Dr. Reddy's Laboratories Regulatory Approval

Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.

Regulatory ApprovalEmmbi Industries Ltd EMMBIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Emmbi Industries Regulatory Approval

SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.